Polyendocrine metabolic ovarian syndrome (PMOS), affecting approximately 11-13% of adolescent girls and women of reproductive age, is characterized by anovulation. Evidence indicates that impaired endometrial receptivity and decidualization significantly contribute to infertility, recurrent pregnancy loss, and adverse pregnancy outcomes such as miscarriage, gestational diabetes, pregnancy-induced hypertension, preeclampsia, and preterm birth. Women with PMOS frequently experience obesity, insulin resistance, and chronic inflammation.
Mechanisms of PMOS
Research explores the cellular and molecular mechanisms by which PMOS disrupts endometrial function. Hyperandrogenism, insulin resistance, obesity, and chronic inflammation collectively impair endometrial receptivity through alterations in androgen receptor signaling, glucose metabolism, extracellular matrix remodeling, immune homeostasis, cell-cell junctions, adhesion molecules, and key regulators of decidualization. Transcriptomic and single-cell sequencing studies have revealed cell type-specific alterations and molecular heterogeneity within the PMOS endometrium.
Goals of Research
These investigations aim to improve embryo implantation success, pregnancy outcomes, and reproductive health in women with PMOS. Further understanding of the connections between endocrine and metabolic abnormalities and endometrial dysfunction is needed.